Bank of New York Mellon Corp - FORMA THERAPEUTICS HLDGS INC ownership

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of FORMA THERAPEUTICS HLDGS INC
ValueSharesWeighting
Q3 2022$2,506,000
+250.0%
125,574
+20.8%
0.00%
Q2 2022$716,000
-33.2%
103,958
-9.8%
0.00%
Q1 2022$1,072,000
-35.1%
115,290
-0.8%
0.00%
Q4 2021$1,653,000
-36.9%
116,215
+2.8%
0.00%
-100.0%
Q3 2021$2,621,000
+7.8%
113,038
+15.7%
0.00%
Q2 2021$2,431,000
-1.7%
97,665
+10.7%
0.00%
-100.0%
Q1 2021$2,472,000
+16.0%
88,227
+44.5%
0.00%
Q4 2020$2,131,000
-7.5%
61,054
+32.2%
0.00%
-100.0%
Q3 2020$2,303,00046,1940.00%
Other shareholders
FORMA THERAPEUTICS HLDGS INC shareholders Q4 2022
NameSharesValueWeighting ↓
EDBI Pte Ltd 1,268,805$8,742,0008.10%
Samsara BioCapital, LLC 1,565,526$10,786,0002.88%
Deep Track Capital, LP 4,050,000$27,905,0001.83%
RA Capital Management 9,011,651$62,090,0001.66%
Cormorant Asset Management, LP 3,172,204$21,856,0001.65%
ARMISTICE CAPITAL, LLC 4,736,000$32,631,0000.57%
SILVERARC CAPITAL MANAGEMENT, LLC 94,386$650,0000.20%
Parkman Healthcare Partners LLC 78,603$542,0000.20%
Integral Health Asset Management, LLC 130,051$896,0000.18%
Opaleye Management Inc. 58,700$404,0000.18%
View complete list of FORMA THERAPEUTICS HLDGS INC shareholders